InvestSMART

Memphasys Limited (ASX:MEM)

ALERT: Price-sensitive ASX Announcement for MEM
Current share price for MEM : $0.005 -0.001 (-16.67%)+
Announcement
Release
20 Aug 2026 8:48AM
Price at Release
$0.006
Full Release
download
Summary
Memphasys Limited has successfully registered its Felix™ System in Vietnam as of August 2026, triggering a commercial order of 600 cartridges by TMSC Vietnam, as part of a two-year exclusive agreement valued at A$530,000. This registration marks the beginning of full commercial sales in Vietnam, one of South-East Asia's rapidly growing assisted reproductive technology markets. TMSC Vietnam has already introduced Felix™ to fertility clinics, reporting the first successful pregnancy using the system, highlighting the system's potential in improving reproductive outcomes. Memphasys will continue to focus on market development and product education alongside TMSC Vietnam to foster clinic adoption. The Felix™ System, which utilizes a unique bio separation technology for enhanced sperm selection, aims to replace traditional centrifugation methods, offering a more efficient and less damaging alternative for clinicians.
Key Points
  • Vietnamese registration for the Felix™ System achieved in August 2026.
  • Registration triggers TMSC Vietnam’s first commercial order of 600 Felix™ cartridges.
  • The order is part of a two-year A$530,000 exclusive commercialisation agreement.
  • First successful pregnancy reported following use of Felix™.
  • TMSC Vietnam facilitates the introduction of Felix™ to fertility clinics.
  • Full commercial sales in Vietnam commence.
  • Memphasys supports training, product education, and clinic engagement.
  • Felix™ System is a patented bio separation technology for sperm selection.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.